Development and validation of an artificial intelligence system for triple-negative breast cancer identification and prognosis prediction: a multicentre retrospective study
Open Access
- 10 October 2025
- journal article
- Published by Elsevier in eClinicalMedicine
- Vol. 89, 103557
Abstract
No abstract availableKeywords
Funding Information
- Natural Science Foundation of Zhejiang Province (LHDMZ25H160002)
- National Natural Science Foundation of China (62202403)
- National Natural Science Foundation of China (62402458)
- Innovation and Technology Commission (MHP/002/22)
- Innovation and Technology Commission (ITCPD/17-9)
This publication has 40 references indexed in Scilit:
- Deep learning framework for comprehensive molecular and prognostic stratifications of triple-negative breast cancerFundamental Research, 2024
- Triple‐negative breast cancer survival prediction using artificial intelligence through integrated analysis of tertiary lymphoid structures and tumor buddingCancer, 2024
- Artificial intelligence‐based digital scores of stromal tumour‐infiltrating lymphocytes and tumour‐associated stroma predict disease‐specific survival in triple‐negative breast cancerThe Journal of Pathology, 2023
- Pan-cancer integrative histology-genomic analysis via multimodal deep learningCancer Cell, 2022
- Abundance of reactive oxygen species (ROS) is associated with tumor aggressiveness, immune response, and worse survival in breast cancerBreast Cancer Research and Treatment, 2022
- A Computational Tumor-Infiltrating Lymphocyte Assessment Method Comparable with Visual Reporting Guidelines for Triple-Negative Breast CancerEBioMedicine, 2021
- Analysis of tumor nuclear features using artificial intelligence to predict response to neoadjuvant chemotherapy in high-risk breast cancer patientsBreast Cancer Research and Treatment, 2021
- Cytologic features of triple‐negative breast carcinomaCancer Cytopathology, 2012
- Concepts of metastasis in flux: The stromal progression modelSeminars in Cancer Biology, 2012
- Prognostic markers in triple‐negative breast cancerCancer, 2006